Publications by authors named "Marion Nonn"

Claim this Profile
R
Rapid identification and sorting of viable virus-reactive CD4(+) and CD8(+) T cells based on antigen-triggered CD137 expression.
Thomas C Wehler, Michael Karg, Eva Distler, Abdo Konur, Marion Nonn

J Immunol Methods· November 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Selective depletion of alloreactive T lymphocytes using patient-derived nonhematopoietic stimulator cells in allograft engineering.
Marion Nonn, Wolfgang Herr, Shamsul Khan, Mariya Todorova, Irina Link

Transplantation· November 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acute myeloid leukemia (AML)-reactive cytotoxic T lymphocyte clones rapidly expanded from CD8(+) CD62L((high)+) T cells of healthy donors prevent AML engraftment in NOD/SCID IL2Rgamma(null) mice.
Eva Distler, Catherine Wölfel, Sylvia Köhler, Marion Nonn, Nina Kaus

Exp Hematol· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Depletion of alloreactive donor T lymphocytes by CD95-mediated activation-induced cell death retains antileukemic, antiviral, and immunoregulatory T cell immunity.
Udo F Hartwig, Marion Nonn, Shamsul Khan, Irina Link, Christoph Huber

Biol Blood Marrow Transplant· January 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting the activation-induced antigen CD137 can selectively deplete alloreactive T cells from antileukemic and antitumor donor T-cell lines.
Thomas C Wehler, Marion Nonn, Britta Brandt, Cedrik M Britten, Mark Gröne

Blood· January 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Superior antitumor in vitro responses of allogeneic matched sibling compared with autologous patient CD8+ T cells.
Sandra Kausche, Thomas Wehler, Elke Schnürer, Volker Lennerz, Walburgis Brenner, Marion Nonn

Cancer Res· December 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dendritic cell-based tumor vaccine for cervical cancer II: results of a clinical pilot study in 15 individual patients.
Alfonso Ferrara, Marion Nonn, Peter Sehr, Carola Schreckenberger, Michael Pawlita

J Cancer Res Clin Oncol· September 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dendritic cell-based tumor vaccine for cervical cancer I: in vitro stimulation with recombinant protein-pulsed dendritic cells induces specific T cells to HPV16 E7 or HPV18 E7.
Marion Nonn, Manuela Schinz, Klaus Zumbach, Michael Pawlita, Achim Schneider

J Cancer Res Clin Oncol· September 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of a naturally processed HLA-A*0201 HPV18 E7 T cell epitope by tumor cell mediated in vitro vaccination.
Angela Kather, Alfonso Ferrara, Marion Nonn, Manuela Schinz, John Nieland

Int J Cancer· April 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis